WO2023037246 - USE OF BACILLUS AMYLOLIQUEFACIENS FOR PREVENTING AND TREATING PARKINSON'S DISEASE
National phase entry:
Publication Number
WO/2023/037246
Publication Date
16.03.2023
International Application No.
PCT/IB2022/058381
International Filing Date
06.09.2022
Title **
[English]
USE OF BACILLUS AMYLOLIQUEFACIENS FOR PREVENTING AND TREATING PARKINSON'S DISEASE
[French]
UTILISATION DE BACILLUS AMYLOLIQUEFACIENS POUR PRÉVENIR ET TRAITER LA MALADIE DE PARKINSON
Applicants **
ARTUGEN THERAPEUTICS LTD.
c/o Byrne Wallace
88, Harcourt Street
Dublin 2, IE
Inventors
ACTON, Susan L.
42 Munroe Rd
Lexington, Massachusetts 02421, US
CHESNEL, Laurent
23 rue Droite
82140 Sant Antonin Noble Val, FR
Priority Data
63/241,442
07.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2353 | |
| EPO | Filing, Examination | 16733 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 8710 |
Total: 28962 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
bacteria, identified as ART24 and ART12, to a subject suffering from or at risk for Parkinson's disease.[French]
, identifiées comme ART24 et ART12, à un sujet souffrant ou présentant un risque de souffrir de la maladie de Parkinson.